Related Experiment Video
Updated: Sep 13, 2025

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
Continuous glucose monitoring in gestational diabetes mellitus: hope or hype?
Thora Y Chai1, Samuel Leathwick2, Mukesh M Agarwal3
1Macarthur Diabetes Service, Campbelltown Hospital, Campbelltown, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia; Macarthur Clinical School, Western Sydney University, Campbelltown, NSW, Australia.
Abstract:
The screening, diagnosis and management of gestational diabetes mellitus (GDM) have evolved over time. Similarly, continuous glucose monitoring (CGM) has advanced in parallel: from intermittent to real-time monitoring, shorter to longer wear-time and poor to increased precision. Thus, CGM has replaced multiple glucose fingerstick testing in type 1 diabetes mellitus (T1D), including pregnant women with T1D. Despite its advantages, the uptake of CGM in women with GDM remains limited. Doubts persist over its cost, accuracy and optimal utilisation, besides there is paucity of evidence supporting its use in both diagnosis and management. This review summarises the current clinical evidence, benefits and limitations of using CGM in pregnant women with GDM. Like T1D, only larger pointed studies and randomised controlled trials will clarify the value of CGM in GDM.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypoglycemia and Glucagon
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Diabetes: Symptoms, Diagnosis, and Complications
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

